3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Motor Activity
9
Neoplasms
6
Pancreatic Neoplasms
3
Lung Neoplasms
3
Breast Neoplasms
3
Esophageal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Peripheral Nervous System Diseases
1
Neurocognitive Disorders
1
Disease
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Cognitive Dysfunction
1
Interventions
durvalumab
2
Tretinoin
2
Paclitaxel
2
Carboplatin
2
zanidatamab
1
veliparib
1
tucatinib
1
trilaciclib
1
trebananib
1
trastuzumab duocarmazine
1
talazoparib
1
sarilumab
1
pexidartinib
1
pertuzumab
1
pembrolizumab
1
patritumab
1
olaparib
1
niraparib
1
neratinib
1
ganitumab
1
dostarlimab
1
cemiplimab
1
abemaciclib
1
Trastuzumab
1
Standard of Care
1
STA 9090
1
SGN-LIV1A
1
Pemetrexed
1
MK 2206
1
Letrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pathologic Complete Response
×
Exercise
×
30 days
×
Clear all
No trials found.